233 related articles for article (PubMed ID: 26113896)
21. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
22. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
23. Effect of interrupting prenatal Down syndrome screening due to a large nuchal translucency.
Wald NJ; Bestwick JP; Huttly WJ
Prenat Diagn; 2012 Jul; 32(7):655-61. PubMed ID: 22573464
[TBL] [Abstract][Full Text] [Related]
24. [First trimester screening for Down syndrome: five years prospective experience].
Weingertner AS; Trieu NT; Kohler M; Viville B; Levy G; Montaya Y; Kutnahorsky R; Tissier I; Kohler A; Tanghe M; Mager C; Benassi E; Cancelier M; Neuman M; Bouffet N; Hunsinger MC; Hornecker F; Langer B; Nisand I; Favre R
J Gynecol Obstet Biol Reprod (Paris); 2010 Sep; 39(5):353-61. PubMed ID: 20541874
[TBL] [Abstract][Full Text] [Related]
25. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus.
Kelekci S; Yilmaz B; Savan K; Sonmez S
J Obstet Gynaecol; 2005 Aug; 25(6):579-82. PubMed ID: 16234144
[TBL] [Abstract][Full Text] [Related]
26. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
[TBL] [Abstract][Full Text] [Related]
27. Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy?
Engels MA; Heijboer AC; Blankenstein MA; van Vugt JM
Prenat Diagn; 2011 Dec; 31(13):1241-5. PubMed ID: 22025131
[TBL] [Abstract][Full Text] [Related]
28. More invasive procedures are done to detect each case of Down's syndrome in younger women.
Marttala J; Ranta JK; Kaijomaa M; Nieminen P; Laitinen P; Kokkonen H; Romppanen J; Hamalainen E; Kultti J; Tekay A; Ulander VM; Honkasalo T; Ryynanen M
Acta Obstet Gynecol Scand; 2011 Jun; 90(6):642-7. PubMed ID: 21355862
[TBL] [Abstract][Full Text] [Related]
29. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
30. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
31. Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH
Prenat Diagn; 2011 Jan; 31(1):7-15. PubMed ID: 21210475
[TBL] [Abstract][Full Text] [Related]
32. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
Conner P; Gustafsson S; Kublickas M
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
[TBL] [Abstract][Full Text] [Related]
33. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
[TBL] [Abstract][Full Text] [Related]
34. First trimester fetal nuchal translucency: problems with screening the general population. 1.
Roberts LJ; Bewley S; Mackinson AM; Rodeck CH
Br J Obstet Gynaecol; 1995 May; 102(5):381-5. PubMed ID: 7612531
[TBL] [Abstract][Full Text] [Related]
35. [The findings and sequence of events leading to termination of pregnancy due to Down's syndrome--before and after the verge of viability: 10 years experience at a single medical center].
Baruchin O; Maymon R; Herman A; Tuvbin Y; Barel O; Zimerman A; Vaknin Z
Harefuah; 2012 Nov; 151(11):602-6, 656. PubMed ID: 23367726
[TBL] [Abstract][Full Text] [Related]
36. Fetal nuchal translucency thickness in different cut-off points for aneuploidy screening in the south of Vietnam.
Tomai XH; Schaaps JP; Foidart JM
J Obstet Gynaecol Res; 2011 Oct; 37(10):1327-34. PubMed ID: 21535312
[TBL] [Abstract][Full Text] [Related]
37. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses.
Maymon R; Zimerman AL; Weinraub Z; Herman A; Cuckle H
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):501-5. PubMed ID: 18512852
[TBL] [Abstract][Full Text] [Related]
38. Increased nuchal translucency in the presence of normal chromosomes: what's next?
Alamillo CM; Fiddler M; Pergament E
Curr Opin Obstet Gynecol; 2012 Mar; 24(2):102-8. PubMed ID: 22277886
[TBL] [Abstract][Full Text] [Related]
39. Quality management of nuchal translucency measurement in residents.
Frey Tirri B; Troeger C; Holzgreve W; Tercanli S
Ultraschall Med; 2007 Oct; 28(5):484-8. PubMed ID: 17918045
[TBL] [Abstract][Full Text] [Related]
40. [Down syndrome screening by ultrasound].
Rozenberg P
Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
